Services
ION CHANNEL SCREENING SERVICES
Ion channel screening
High-throughput screening
CARDIAC SAFETY SCREENING SERVICES
Cardiac Safety Screening
GLP hERG Testing
Non-GLP hERG Screening
A clinically translatable hiPSC cardiomyocyte assay for early cardiac derisking
hiPSC-derived Cardiomyocyte Screening
Chronic Cardiotoxicity Assay: hiPSC-derived Cardiomyocytes
CiPA Screening
NEUROSCIENCE SERVICES
Neuroscience
CNS drug discovery: Brain slice tissue
Native Neuronal Ion Channels
Central Neuronal Firing
Peripheral Neuronal Firing
Neuroscience translational assays
INTEGRATED SERVICES
Integrated Drug Discovery
Who we are
Why Metrion?
Why Choose Metrion As Your CRO?
Who we work with
Leadership
Metrion Board
Metrion Leadership Team
About Metrion
Metrion Company History
Mission, Vision, Values
Metrion Annual Reports
Join Metrion
Careers
Knowledge Library
KNOWLEDGE LIBRARY
Resources
News & Events
News
News and Press Releases
Events
Upcoming Events
Contact
CONTACT
Contact
EN/日本語
English
日本語
Services
ION CHANNEL SCREENING SERVICES
Ion channel screening
High-throughput screening
CARDIAC SAFETY SCREENING SERVICES
Cardiac Safety Screening
GLP hERG Testing
Non-GLP hERG Screening
A clinically translatable hiPSC cardiomyocyte assay for early cardiac derisking
hiPSC-derived Cardiomyocyte Screening
Chronic Cardiotoxicity Assay: hiPSC-derived Cardiomyocytes
CiPA Screening
NEUROSCIENCE SERVICES
Neuroscience
CNS drug discovery: Brain slice tissue
Native Neuronal Ion Channels
Central Neuronal Firing
Peripheral Neuronal Firing
Neuroscience translational assays
INTEGRATED SERVICES
Integrated Drug Discovery
Who we are
Why Metrion?
Why Choose Metrion As Your CRO?
Who we work with
Leadership
Metrion Board
Metrion Leadership Team
About Metrion
Metrion Company History
Mission, Vision, Values
Metrion Annual Reports
Join Metrion
Careers
Knowledge Library
KNOWLEDGE LIBRARY
Resources
News & Events
News
News and Press Releases
Events
Upcoming Events
Contact
CONTACT
Contact
EN/日本語
English
日本語
Home
>
News and Press Releases
>
Page 4
Filters
Filters
Resource Type
- Select Resource Type -
Blog
Press releases
Topic
- Select Topic -
Cardiac Safety Screening
Corporate
Ion Channel Screening
Neuroscience
Show
(
105
)
Cancel
Metrion Biosciences appoints Dr Steve Jenkinson as VP, Drug Discovery and Safety Assessment to strengthen US Operations
June 12, 2023
Read More
Jack - My Academic and Professional Career So Far!
May 5, 2023
Read More
Zeki - From Ants to Ion Channels
February 10, 2023
Read More
Thomas's Career So Far
January 9, 2023
Read More
Katie - Expanding my skills to the world of ion channels
January 9, 2023
Read More
Metrion Biosciences and the KCNC1 Foundation collaborate on development of new ion channel modulators for ultra-rare genetic disorder
December 7, 2022
Read More
Metrion Biosciences invests in new High Throughput Screening capability and expanded facilities
November 30, 2022
Read More
Catherine's Career So Far
October 10, 2022
Written by Dr. Catherine Hodgson
Read More
Yasmin - About Me
October 10, 2022
Read More
Metrion Biosciences appoints Dr Benedetta Montagnini as head of European Business Development
June 9, 2022
Read More
« Previous
1
2
3
4
5
6
…
11
Next »
DisPATCHes newsletter
Subscribe to DisPATCHes newsletter
Let’s work together
Contact us for a quote or discussion
Search metrionbiosciences.com
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
About Metrion
Metrion Biosciences is a contract research organisation (CRO) specialising in high-quality preclinical drug discovery services.
Visit our LinkedIn
Visit our Twitter
Links
Ion Channel Screening
Cardiac Safety Screening
Neuroscience
Integrated Drug Discovery
Our Approach
Knowledge Library
News & Events
Contact
SUBSCRIBE TO NEWSLETTER
Copyright © 2024 Metrion. All rights reserved |
Privacy notice
| Registered as a company in England and Wales: 09669815 | VAT: GB 219828479
magnifier
linkedin
facebook
pinterest
youtube
rss
twitter
instagram
facebook-blank
rss-blank
linkedin-blank
pinterest
youtube
twitter
instagram
